Literature DB >> 6268830

XbaI, PstI, and BglII restriction enzyme maps of the two orientations of the varicella-zoster virus genome.

A M Dumas, J L Geelen, M W Weststrate, P Wertheim, J van der Noordaa.   

Abstract

Cleavage of varicella-zoster virus DNA with the restriction endonucleases PstI, XbaI, and BglII resulted in 18, 22, and 20 fragments, respectively. Based on the molecular weights and molarities of these fragments, a molecular weight of 84 x 10(6) could be calculated for the varicella-zoster virus genome. In both the XbaI and the BglII patterns, four 0.5 M fragments were identified. The arrangement of the fragments was determined by molecular hybridization techniques, and the terminal fragments were identified by lambda exonuclease digestion. The 0.5 M fragments, of which two were located at the same terminus of the genome, contained repeated sequences: one terminally and one inverted internally. These results were in agreement with the existence of two equimolar subpopulations of the varicella-zoster virus genome, differing in the relative orientation of a short region of unique sequences. This region was bounded by the repeated sequences. From the molecular weights of the submolar fragments, a maximal molecular weight of 5 x 10(6) for the repeated region and a minimal molecular weight of 3.5 x 10(6) for the short unique sequence could be calculated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6268830      PMCID: PMC171347     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Analysis of bacteriophage mu and lambda-mu hybrid DNAs by specific endonucleases.

Authors:  B Allet; A I Bukhari
Journal:  J Mol Biol       Date:  1975-03-15       Impact factor: 5.469

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Structure and function of herpesvirus genomes. II. EcoRl, Sbal, and HindIII endonuclease cleavage sites on herpes simplex virus.

Authors:  J Skare; W C Summers
Journal:  Virology       Date:  1977-02       Impact factor: 3.616

4.  Inverted repetition in the chromosome of pseudorabies virus.

Authors:  W S Stevely
Journal:  J Virol       Date:  1977-04       Impact factor: 5.103

5.  The cleavage of polyoma virus DNA by restriction enzymes KpnI and PstI.

Authors:  L V Crawford; A K Robbins
Journal:  J Gen Virol       Date:  1976-06       Impact factor: 3.891

Review 6.  Nucleotide sequence analysis of bacteriophage DNA.

Authors:  R Wu; R Padmanabhan; R Bambara
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

7.  The characterization of Varicella-zoster virus DNA.

Authors:  H Ludwig; H G Haines; N Biswal; M Benyesh-Melnick
Journal:  J Gen Virol       Date:  1972-01       Impact factor: 3.891

8.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

9.  The gel electrophoresis of DNA.

Authors:  C Aaij; P Borst
Journal:  Biochim Biophys Acta       Date:  1972-05-10

10.  An improved technique for obtaining enhanced infectivity with herpes simplex virus type 1 DNA.

Authors:  N D Stow; N M Wilkie
Journal:  J Gen Virol       Date:  1976-12       Impact factor: 3.891

View more
  24 in total

1.  Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination.

Authors:  Winsome Barrett Muir; Richard Nichols; Judith Breuer
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Transcription mapping of the varicella-zoster virus genome.

Authors:  J M Ostrove; W Reinhold; C M Fan; S Zorn; J Hay; S E Straus
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

3.  Putative glycoprotein gene of varicella-zoster virus with variable copy numbers of a 42-base-pair repeat sequence has homology to herpes simplex virus glycoprotein C.

Authors:  P R Kinchington; J Remenick; J M Ostrove; S E Straus; W T Ruyechan; J Hay
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

4.  Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping.

Authors:  Vladimir N Loparev; Antonio Gonzalez; Marlene Deleon-Carnes; Graham Tipples; Helmut Fickenscher; Einar G Torfason; D Scott Schmid
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

5.  Physical maps of varicella-zoster virus DNA derived with 11 restriction enzymes.

Authors:  L Mishra; D E Dohner; W J Wellinghoff; L D Gelb
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

6.  Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant viruses found in North America: evolution of genotypes with an accelerated cell spread phenotype.

Authors:  Charles Grose; Shaun Tyler; Geoff Peters; Joanne Hiebert; Gwen M Stephens; William T Ruyechan; Wallen Jackson; Johnathan Storlie; Graham A Tipples
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

7.  Detection of varicella-zoster virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients suffering from neurological complications associated with chicken pox or herpes zoster.

Authors:  E Puchhammer-Stöckl; T Popow-Kraupp; F X Heinz; C W Mandl; C Kunz
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

8.  Molecular cloning and physical mapping of varicella-zoster virus DNA.

Authors:  S E Straus; J Owens; W T Ruyechan; H E Takiff; T A Casey; G F Vande Woude; J Hay
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

9.  Genome variation among varicella-zoster virus isolates derived from different individuals and from the same individuals.

Authors:  R Hondo; Y Yogo; T Kurata; Y Aoyama
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

10.  Lineages of varicella-zoster virus.

Authors:  Duncan J McGeoch
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.